Westlake Chemical Partners (WLKP) Financials

$22.28 -0.26 (-1.13%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$22.28 0.00 (0.00%)

As of 05/23/2025 04:04 PM Eastern

Annual Income Statements for Westlake Chemical Partners

This table shows Westlake Chemical Partners' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	62	54	64	83	66	61	49	49	41	40	510
Consolidated Net Income / (Loss)	369	335	335	401	341	333	331	353	353	354	510
Net Income / (Loss) Continuing Operations	369	335	335	401	341	333	331	353	353	354	510
Total Pre-Tax Income	370	335	336	402	342	334	331	354	354	355	709
Total Operating Income	390	358	348	411	353	350	350	374	366	359	717
Total Gross Profit	419	387	377	442	379	379	377	404	391	383	746
Total Revenue	1,136	1,191	1,593	1,215	967	1,092	1,075	973	854	1,007	1,750
Operating Revenue	1,136	1,191	1,593	1,215	967	1,092	1,075	973	854	835	1,292
Total Cost of Revenue	717	803	1,216	773	588	712	698	569	462	624	1,004
Operating Cost of Revenue	717	803	1,216	773	588	712	698	569	462	624	1,004
Total Operating Expenses	28	30	30	31	26	29	28	29	25	24	29
Selling, General & Admin Expense	28	30	30	31	26	29	28	29	25	24	29
Total Other Income / (Expense), net	-20	-22	-12	-8.75	-11	-17	-19	-20	-12	-4.81	-7.35
Interest Expense	26	27	13	8.82	12	20	21	22	13	4.97	10
Other Income / (Expense), net	5.25	4.23	1.57	0.06	0.73	3.10	2.46	1.79	0.60	0.16	3.15
Income Tax Expense	0.84	0.81	1.02	0.55	0.56	0.73	0.02	1.28	1.04	0.67	199
Net Income / (Loss) Attributable to Noncontrolling Interest	307	280	271	319	275	272	281	304	312	314	-
Basic Earnings per Share	$1.77	$1.54	$1.82	$2.34	$1.88	$1.77	$1.51	$1.43	-	-	-
Weighted Average Basic Shares Outstanding	35.24M	35.22M	35.22M	35.21M	35.20M	34.49M	32.24M	28.39M	27.06M	27.06M	27.06M
Diluted Earnings per Share	$1.77	$1.54	$1.82	$2.34	-	-	-	-	-	-	-
Weighted Average Diluted Shares Outstanding	35.24M	35.22M	35.22M	35.21M	35.20M	34.49M	32.24M	28.39M	27.06M	27.06M	27.06M
Weighted Average Basic & Diluted Shares Outstanding	35.23M	35.22M	35.22M	35.21M	35.20M	34.49M	32.24M	28.39M	27.06M	27.06M	27.06M
Cash Dividends to Common per Share	$1.89	$1.89	$1.89	$1.89	$1.89	$1.80	$1.61	$1.44	$1.29	$1.15	-

This table shows Westlake Chemical Partners' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	4.95	15	18	14	15	14	13	12	15	17	15
Consolidated Net Income / (Loss)	42	87	104	88	90	87	81	75	91	91	78
Net Income / (Loss) Continuing Operations	42	87	104	88	90	87	81	75	91	91	78
Total Pre-Tax Income	42	88	104	88	90	87	81	75	92	91	79
Total Operating Income	47	92	110	94	95	93	86	80	98	95	82
Total Gross Profit	54	99	117	101	102	101	93	88	106	98	90
Total Revenue	238	290	277	284	285	297	322	264	308	367	415
Operating Revenue	238	290	277	284	285	297	322	264	308	367	415
Total Cost of Revenue	184	191	160	183	182	197	229	176	202	269	325
Operating Cost of Revenue	184	191	160	183	182	197	229	176	202	269	325
Total Operating Expenses	7.47	6.56	7.25	7.61	7.08	7.87	6.74	7.23	7.91	2.85	8.68
Selling, General & Admin Expense	7.47	6.56	7.25	7.61	7.08	7.87	6.74	7.23	7.91	2.85	8.68
Total Other Income / (Expense), net	-4.19	-4.44	-5.37	-5.39	-5.25	-5.55	-5.17	-5.06	-6.50	-3.82	-3.03
Interest Expense	5.54	5.77	6.70	6.65	6.58	6.63	6.44	6.12	7.32	4.70	3.65
Other Income / (Expense), net	1.35	1.34	1.33	1.26	1.33	1.08	1.27	1.06	0.82	0.88	0.62
Income Tax Expense	0.11	0.20	0.22	0.21	0.21	0.21	0.22	0.17	0.21	0.20	0.48
Net Income / (Loss) Attributable to Noncontrolling Interest	37	72	86	74	75	73	68	63	77	74	64
Basic Earnings per Share	$0.14	$0.43	$0.51	$0.41	$0.42	$0.41	$0.37	$0.34	$0.42	$0.47	$0.42
Weighted Average Basic Shares Outstanding	35.24M	35.24M	35.24M	35.23M	35.23M	35.22M	35.23M	35.22M	35.22M	35.22M	35.22M
Diluted Earnings per Share	$0.14	$0.43	$0.51	$0.41	$0.42	$0.41	$0.37	$0.34	$0.42	$0.47	$0.42
Weighted Average Diluted Shares Outstanding	35.24M	35.24M	35.24M	35.23M	35.23M	35.22M	35.23M	35.22M	35.22M	35.22M	35.22M
Weighted Average Basic & Diluted Shares Outstanding	35.24M	35.23M	35.24M	35.23M	35.23M	35.22M	35.23M	35.22M	35.22M	35.22M	35.22M
Cash Dividends to Common per Share	$0.47	-	$0.47	$0.47	$0.47	-	$0.47	$0.47	$0.47	-	$0.47

This table details how cash moves in and out of Westlake Chemical Partners' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-0.30	-6.16	48	-0.10	-2.77	0.18	-7.26	-62	-81	36	134
Net Cash From Operating Activities	485	452	464	408	373	451	436	537	288	453	604
Net Cash From Continuing Operating Activities	485	452	464	408	373	451	436	537	288	453	604
Net Income / (Loss) Continuing Operations	369	335	335	401	341	333	331	353	353	354	510
Consolidated Net Income / (Loss)	369	335	335	401	341	333	331	353	353	354	510
Depreciation Expense	112	110	121	109	103	107	109	114	98	81	78
Non-Cash Adjustments To Reconcile Net Income	2.16	4.91	5.06	3.92	0.73	0.06	1.50	1.99	3.76	1.53	2.68
Changes in Operating Assets and Liabilities, net	1.78	2.26	2.77	-106	-72	11	-4.76	68	-168	16	14
Net Cash From Investing Activities	-89	-76	-12	-64	2.03	-58	-52	-203	-299	-231	-203
Net Cash From Continuing Investing Activities	-89	-76	-12	-64	2.03	-58	-52	-203	-299	-231	-203
Purchase of Property, Plant & Equipment	-49	-47	-54	-81	-37	-44	-40	-69	-300	-231	-203
Purchase of Investments	-40	-174	-320	-276	-349	-529	-384	-199	0.00	-	-0.13
Sale and/or Maturity of Investments	0.00	145	362	293	388	515	372	63	0.00	-	-
Net Cash From Financing Activities	-396	-382	-404	-344	-378	-393	-392	-396	-69	-186	-267
Net Cash From Continuing Financing Activities	-396	-382	-404	-344	-378	-393	-392	-396	-69	-186	-267
Repayment of Debt	-219	-209	-32	0.00	0.00	-201	0.00	-286	-1.55	-135	-79
Payment of Dividends	-396	-382	-404	-344	-378	-378	-395	-386	-280	-342	-656
Issuance of Debt	219	209	32	0.00	0.00	124	3.65	165	212	292	182

This table details how cash moves in and out of Westlake Chemical Partners' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-8.69	-1.89	-5.79	10	-2.86	-7.25	6.44	-45	40	45	1.10
Net Cash From Operating Activities	46	132	126	122	105	108	101	99	145	123	115
Net Cash From Continuing Operating Activities	46	132	126	122	105	108	101	99	145	123	115
Net Income / (Loss) Continuing Operations	42	87	104	88	90	87	81	75	91	91	78
Consolidated Net Income / (Loss)	42	87	104	88	90	87	81	75	91	91	78
Depreciation Expense	27	27	28	28	28	28	28	27	27	29	29
Non-Cash Adjustments To Reconcile Net Income	0.24	-0.06	0.36	1.34	0.53	0.55	3.63	-0.22	0.94	-3.73	1.99
Changes in Operating Assets and Liabilities, net	-24	18	-6.50	4.21	-14	-8.24	-12	-3.54	26	5.65	5.81
Net Cash From Investing Activities	14	-38	-31	-10	-9.77	-23	-6.81	-47	0.23	62	-19
Net Cash From Continuing Investing Activities	14	-38	-31	-10	-9.77	-23	-6.81	-47	0.23	62	-19
Purchase of Property, Plant & Equipment	-16	-13	-16	-10	-9.77	-13	-17	-4.51	-13	-8.66	-13
Sale and/or Maturity of Investments	30	-	-	-	0.00	-	10	32	103	115	100
Net Cash From Financing Activities	-69	-96	-101	-101	-98	-92	-88	-97	-105	-140	-95
Net Cash From Continuing Financing Activities	-69	-96	-101	-101	-98	-92	-88	-97	-105	-140	-95
Repayment of Debt	-54	-56	-55	-54	-54	-54	-57	-60	-39	-32	-
Payment of Dividends	-69	-96	-101	-101	-98	-92	-88	-97	-105	-140	-95
Issuance of Debt	54	56	55	54	54	54	57	60	39	32	-

This table presents Westlake Chemical Partners' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	1,288	1,317	1,372	1,481	1,356	1,393	1,462	1,515	1,555	1,290	1,096
Total Current Assets	241	226	246	281	263	238	247	231	232	225	197
Cash & Equivalents	58	59	65	17	17	20	20	27	89	170	134
Short-Term Investments	135	94	-	-	123	-	149	-	-	-	-
Accounts Receivable	44	68	111	149	119	53	74	62	139	52	56
Inventories, net	4.06	4.43	4.72	8.90	3.47	2.48	4.39	5.59	3.93	3.88	6.63
Prepaid Expenses	0.44	0.44	0.31	0.40	0.39	0.47	0.37	0.31	0.27	0.27	0.21
Plant, Property, & Equipment, net	904	944	990	1,044	1,051	1,103	1,148	1,196	1,222	1,020	842
Total Noncurrent Assets	143	147	136	156	43	52	67	88	101	45	58
Goodwill	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81	5.81
Other Noncurrent Operating Assets	138	141	130	150	37	46	61	82	95	39	52
Total Liabilities & Shareholders' Equity	1,288	1,317	1,372	1,481	1,356	1,393	1,462	1,515	1,555	1,290	1,096
Total Liabilities	459	461	468	508	441	441	528	517	634	443	261
Total Current Liabilities	55	56	67	107	40	39	49	40	38	58	32
Accounts Payable	38	31	49	46	21	21	33	25	22	34	20
Accrued Expenses	17	25	18	61	19	18	16	16	16	23	12
Total Noncurrent Liabilities	403	404	401	401	402	402	479	476	596	385	230
Long-Term Debt	400	400	400	-	-	-	-	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	1.55	1.63	1.66	1.53	1.54	1.65	1.66	2.22	1.74	1.39	1.85
Other Noncurrent Operating Liabilities	2.05	2.95	0.00	-	0.38	1.15	0.00	0.11	0.12	0.09	0.02
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	829	856	904	973	915	1,265	934	999	921	847	835
Total Preferred & Common Equity	276	280	292	294	313	590	216	220	103	97	88
Total Common Equity	276	280	292	294	277	590	216	220	103	97	88
Common Stock	276	280	292	294	313	590	216	220	102	97	88
Noncontrolling Interest	553	576	612	679	638	675	718	779	818	751	747

This table presents Westlake Chemical Partners' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023
Total Assets	1,371	1,295	1,288	1,295	1,342	1,336	1,343
Total Current Assets	225	242	232	224	231	221	232
Cash & Equivalents	50	60	66	56	66	59	105
Short-Term Investments	105	110	-	-	-	94	52
Accounts Receivable	68	67	66	69	76	63	70
Inventories, net	2.73	3.75	4.49	4.86	4.39	3.26	5.47
Prepaid Expenses	0.20	0.67	0.94	0.26	0.60	0.72	0.15
Plant, Property, & Equipment, net	903	909	913	927	959	963	977
Total Noncurrent Assets	243	144	143	144	151	152	133
Goodwill	5.81	5.81	5.81	5.81	5.81	5.81	5.81
Other Noncurrent Operating Assets	237	138	138	138	145	146	127
Total Liabilities & Shareholders' Equity	1,371	1,295	1,288	1,295	1,342	1,336	1,343
Total Liabilities	568	457	454	447	480	468	453
Total Current Liabilities	165	53	50	43	76	66	51
Accounts Payable	101	32	28	23	44	39	30
Accrued Expenses	63	21	22	20	31	27	21
Total Noncurrent Liabilities	403	404	404	404	405	401	401
Long-Term Debt	400	400	400	400	400	400	-
Noncurrent Deferred & Payable Income Tax Liabilities	1.57	1.57	1.68	1.66	1.66	1.64	1.64
Other Noncurrent Operating Liabilities	2.18	2.35	2.55	2.41	3.31	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	803	838	835	848	861	868	890
Total Preferred & Common Equity	264	278	276	278	282	286	290
Total Common Equity	264	278	276	278	282	286	290
Common Stock	264	278	276	278	282	286	290
Noncontrolling Interest	539	560	559	570	579	582	600

This table displays calculated financial ratios and metrics derived from Westlake Chemical Partners' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.61%	-25.26%	31.14%	25.67%	-11.47%	1.57%	10.47%	13.98%	-15.24%	-42.43%	0.00%
EBITDA Growth	7.51%	0.39%	-9.48%	13.72%	-0.80%	-0.07%	-5.98%	5.36%	5.57%	-44.73%	0.00%
EBIT Growth	9.33%	3.63%	-14.97%	16.12%	0.13%	0.35%	-6.43%	2.49%	2.10%	-50.05%	0.00%
NOPAT Growth	9.17%	2.94%	-15.48%	16.38%	0.86%	-0.05%	-6.30%	2.10%	1.87%	-30.37%	0.00%
Net Income Growth	10.32%	-0.06%	-16.58%	17.67%	2.47%	0.70%	-6.37%	-0.10%	-0.13%	-30.59%	0.00%
EPS Growth	14.94%	-15.38%	-22.22%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	7.30%	-2.53%	13.54%	9.38%	-17.17%	3.36%	-18.83%	86.76%	-36.42%	-25.08%	0.00%
Free Cash Flow Firm Growth	-7.36%	6.31%	102.12%	-55.04%	95.73%	-52.83%	55.99%	119,533.77%	-99.87%	0.00%	0.00%
Invested Capital Growth	-6.05%	-10.96%	-8.61%	15.40%	-11.82%	7.15%	-14.02%	1.33%	34.39%	14.29%	0.00%
Revenue Q/Q Growth	-0.63%	-5.52%	0.00%	2.00%	-4.75%	8.12%	13.21%	-1.36%	-9.30%	0.00%	0.00%
EBITDA Q/Q Growth	-0.27%	-0.71%	0.00%	13.99%	-4.24%	2.09%	-3.47%	0.15%	3.71%	0.00%	0.00%
EBIT Q/Q Growth	-0.14%	-0.62%	0.00%	18.17%	-5.02%	2.66%	-4.29%	1.07%	1.80%	0.00%	0.00%
NOPAT Q/Q Growth	-0.20%	-0.69%	0.00%	18.18%	-4.88%	2.73%	-4.48%	1.14%	1.75%	0.00%	0.00%
Net Income Q/Q Growth	0.09%	-1.24%	0.00%	18.71%	-4.69%	3.20%	-4.82%	1.36%	0.69%	0.00%	0.00%
EPS Q/Q Growth	1.14%	-3.75%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	5.39%	-3.19%	0.00%	-2.54%	-18.21%	2.15%	-6.29%	4.90%	-3.68%	0.74%	0.00%
Free Cash Flow Firm Q/Q Growth	-11.86%	158.94%	-63.97%	-39.09%	117.72%	-54.37%	34.83%	8.08%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-2.96%	-7.72%	0.00%	5.40%	-10.70%	12.98%	-11.83%	-0.53%	1.04%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.88%	32.54%	23.69%	36.36%	39.19%	34.75%	35.09%	41.48%	45.84%	38.01%	42.63%
EBITDA Margin	44.69%	39.65%	29.52%	42.77%	47.26%	42.18%	42.87%	50.37%	54.50%	43.75%	45.57%
Operating Margin	34.37%	30.04%	21.82%	33.81%	36.52%	32.07%	32.52%	38.48%	42.92%	35.68%	40.95%
EBIT Margin	34.84%	30.39%	21.92%	33.81%	36.59%	32.35%	32.75%	38.66%	42.99%	35.69%	41.13%
Profit (Net Income) Margin	32.50%	28.10%	21.02%	33.04%	35.29%	30.49%	30.75%	36.28%	41.40%	35.13%	29.14%
Tax Burden Percent	99.77%	99.76%	99.70%	99.86%	99.83%	99.78%	99.99%	99.64%	99.71%	99.81%	71.89%
Interest Burden Percent	93.50%	92.68%	96.16%	97.85%	96.60%	94.44%	93.91%	94.19%	96.57%	98.62%	98.54%
Effective Tax Rate	0.23%	0.24%	0.30%	0.14%	0.17%	0.22%	0.01%	0.36%	0.29%	0.19%	28.11%
Return on Invested Capital (ROIC)	36.43%	30.48%	26.73%	32.42%	28.12%	27.14%	26.00%	25.98%	29.37%	36.04%	55.46%
ROIC Less NNEP Spread (ROIC-NNEP)	27.43%	22.84%	23.44%	29.70%	21.20%	18.37%	20.98%	21.78%	26.04%	32.92%	49.83%
Return on Net Nonoperating Assets (RNNOA)	7.38%	7.55%	8.96%	10.10%	3.17%	3.14%	8.20%	10.80%	10.60%	6.03%	5.60%
Return on Equity (ROE)	43.80%	38.03%	35.69%	42.52%	31.30%	30.28%	34.20%	36.77%	39.96%	42.07%	61.06%
Cash Return on Invested Capital (CROIC)	42.67%	42.07%	35.73%	18.12%	40.69%	20.23%	41.08%	24.65%	0.02%	22.70%	0.00%
Operating Return on Assets (OROA)	30.38%	26.92%	24.49%	28.95%	25.73%	24.74%	23.65%	24.50%	25.80%	30.12%	67.33%
Return on Assets (ROA)	28.34%	24.89%	23.47%	28.29%	24.81%	23.32%	22.21%	23.00%	24.84%	29.65%	47.69%
Return on Common Equity (ROCE)	14.45%	12.36%	11.14%	12.87%	12.46%	11.10%	7.71%	6.18%	4.51%	4.61%	25.69%
Return on Equity Simple (ROE_SIMPLE)	133.69%	119.54%	114.70%	136.54%	109.12%	56.40%	153.18%	160.41%	344.17%	365.40%	582.49%
Net Operating Profit after Tax (NOPAT)	390	357	347	410	352	349	350	373	365	359	515
NOPAT Margin	34.30%	29.97%	21.76%	33.76%	36.46%	32.00%	32.52%	38.34%	42.80%	35.61%	29.44%
Net Nonoperating Expense Percent (NNEP)	9.00%	7.64%	3.29%	2.72%	6.92%	8.77%	5.02%	4.20%	3.33%	3.12%	5.63%
Return On Investment Capital (ROIC_SIMPLE)	31.70%	28.41%	26.60%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	63.12%	67.46%	76.31%	63.64%	60.81%	65.25%	64.91%	58.52%	54.16%	61.99%	57.37%
SG&A Expenses to Revenue	2.51%	2.50%	1.86%	2.55%	2.68%	2.68%	2.57%	3.01%	2.92%	2.34%	1.67%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	2.51%	2.50%	1.86%	2.55%	2.68%	2.68%	2.57%	3.01%	2.92%	2.34%	1.67%
Earnings before Interest and Taxes (EBIT)	396	362	349	411	354	353	352	376	367	359	720
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	508	472	470	520	457	461	461	490	465	441	797
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.90	2.46	2.35	2.69	2.35	1.09	2.36	1.97	3.28	3.34	4.57
Price to Tangible Book Value (P/TBV)	2.96	2.51	2.40	2.75	2.40	1.10	2.42	2.02	3.48	3.56	4.90
Price to Revenue (P/Rev)	0.70	0.58	0.43	0.65	0.68	0.59	0.47	0.44	0.39	0.32	0.23
Price to Earnings (P/E)	12.82	12.68	10.71	9.59	9.87	10.58	10.31	8.89	8.23	8.13	0.79
Dividend Yield	8.31%	9.65%	9.66%	8.39%	10.16%	9.62%	10.22%	9.45%	10.33%	9.60%	1.15%
Earnings Yield	7.80%	7.89%	9.34%	10.43%	10.13%	9.45%	9.70%	11.25%	12.15%	12.30%	127.32%
Enterprise Value to Invested Capital (EV/IC)	1.51	1.37	1.32	1.07	0.98	0.98	0.85	0.82	0.75	0.85	1.09
Enterprise Value to Revenue (EV/Rev)	1.37	1.27	1.03	1.20	1.19	1.19	0.98	1.22	1.25	0.90	0.58
Enterprise Value to EBITDA (EV/EBITDA)	3.07	3.20	3.47	2.80	2.52	2.82	2.30	2.42	2.29	2.05	1.27
Enterprise Value to EBIT (EV/EBIT)	3.94	4.18	4.68	3.54	3.25	3.68	3.01	3.15	2.91	2.52	1.41
Enterprise Value to NOPAT (EV/NOPAT)	4.00	4.24	4.71	3.54	3.26	3.72	3.03	3.18	2.92	2.52	1.97
Enterprise Value to Operating Cash Flow (EV/OCF)	3.22	3.34	3.52	3.56	3.08	2.88	2.43	2.20	3.71	2.00	1.68
Enterprise Value to Free Cash Flow (EV/FCFF)	3.42	3.07	3.53	6.34	2.26	4.99	1.92	3.35	3,603.99	4.01	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.48	0.47	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.48	0.47	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.27	0.33	0.38	0.34	0.15	0.17	0.39	0.50	0.41	0.18	0.11
Leverage Ratio	1.55	1.53	1.52	1.50	1.26	1.30	1.54	1.60	1.61	1.42	1.66
Compound Leverage Factor	1.45	1.42	1.46	1.47	1.22	1.23	1.45	1.51	1.55	1.40	1.63
Debt to Total Capital	32.52%	31.82%	30.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	32.52%	31.82%	30.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	45.01%	45.89%	46.94%	69.78%	69.69%	53.34%	76.90%	77.97%	88.85%	88.57%	89.52%
Common Equity to Total Capital	22.47%	22.29%	22.40%	30.22%	30.31%	46.66%	23.10%	22.03%	11.15%	11.43%	10.48%
Debt to EBITDA	0.79	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.41	0.52	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.79	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	1.03	1.12	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.53	0.69	0.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	1.03	1.12	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	3.12	2.86	3.04	2.81	2.66	2.67	2.27	2.12	1.80	2.29	4.86
Noncontrolling Interest Sharing Ratio	67.01%	67.51%	68.78%	69.73%	60.20%	63.34%	77.45%	83.19%	88.72%	89.04%	57.92%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.35	4.02	3.67	2.63	6.62	6.14	5.07	5.75	6.15	3.90	6.15
Quick Ratio	4.27	3.93	2.63	1.55	6.53	1.87	4.97	2.21	6.03	3.83	5.93
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	456	493	463	229	510	260	552	354	0.30	226	0.00
Operating Cash Flow to CapEx	990.38%	965.38%	856.90%	503.18%	1,010.05%	1,031.43%	1,094.15%	780.38%	96.02%	195.75%	297.80%
Free Cash Flow to Firm to Interest Expense	17.75	18.59	34.56	26.00	42.35	13.27	25.77	16.20	0.02	45.48	0.00
Operating Cash Flow to Interest Expense	18.87	17.06	34.59	46.33	31.02	22.97	20.35	24.58	22.82	91.11	57.53
Operating Cash Flow Less CapEx to Interest Expense	16.97	15.29	30.55	37.12	27.95	20.75	18.49	21.43	-0.94	44.57	38.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.87	0.89	1.12	0.86	0.70	0.76	0.72	0.63	0.60	0.84	1.64
Accounts Receivable Turnover	20.32	13.29	12.27	9.08	11.25	17.27	15.85	9.68	8.96	18.72	27.37
Inventory Turnover	168.89	175.65	178.62	124.98	197.31	207.35	139.87	119.57	118.36	118.77	16.32
Fixed Asset Turnover	1.23	1.23	1.57	1.16	0.90	0.97	0.92	0.80	0.76	1.08	2.18
Accounts Payable Turnover	20.54	19.89	25.51	23.12	27.77	26.45	24.46	24.44	16.41	22.97	14.08
Days Sales Outstanding (DSO)	17.97	27.47	29.74	40.21	32.44	21.13	23.03	37.70	40.75	19.50	13.34
Days Inventory Outstanding (DIO)	2.16	2.08	2.04	2.92	1.85	1.76	2.61	3.05	3.08	3.07	22.36
Days Payable Outstanding (DPO)	17.77	18.35	14.31	15.79	13.14	13.80	14.92	14.94	22.24	15.89	25.93
Cash Conversion Cycle (CCC)	2.36	11.20	17.48	27.34	21.15	9.10	10.72	25.82	21.60	6.68	9.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,036	1,103	1,239	1,355	1,174	1,332	1,243	1,446	1,427	1,062	929
Invested Capital Turnover	1.06	1.02	1.23	0.96	0.77	0.85	0.80	0.68	0.69	1.01	1.88
Increase / (Decrease) in Invested Capital	-67	-136	-117	181	-157	89	-203	19	365	133	0.00
Enterprise Value (EV)	1,560	1,511	1,634	1,453	1,150	1,300	1,058	1,185	1,067	905	1,014
Market Capitalization	800	688	687	792	653	645	509	433	337	324	400
Book Value per Share	$7.84	$7.95	$8.29	$8.35	$7.88	$16.77	$6.69	$6.83	$3.79	$3.58	$3.23
Tangible Book Value per Share	$7.67	$7.78	$8.12	$8.18	$7.72	$16.61	$6.51	$6.65	$3.58	$3.36	$3.02
Total Capital	1,229	1,256	1,303	973	915	1,265	934	999	921	847	835
Total Debt	400	400	400	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	400	400	400	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	207	247	335	-17	-140	-20	-169	-27	-89	-170	-134
Capital Expenditures (CapEx)	49	47	54	81	37	44	40	69	300	231	203
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-7.32	17	114	157	83	180	30	164	105	-1.97	31
Debt-free Net Working Capital (DFNWC)	186	170	179	174	224	200	198	191	194	168	165
Net Working Capital (NWC)	186	170	179	174	224	200	198	191	194	168	165
Net Nonoperating Expense (NNE)	20	22	12	8.74	11	16	19	20	12	4.80	5.28
Net Nonoperating Obligations (NNO)	207	247	335	383	259	67	309	447	506	214	94
Total Depreciation and Amortization (D&A)	112	110	121	109	103	107	109	114	98	81	78
Debt-free, Cash-free Net Working Capital to Revenue	-0.64%	1.41%	7.16%	12.95%	8.60%	16.45%	2.76%	16.87%	12.36%	-0.20%	1.77%
Debt-free Net Working Capital to Revenue	16.34%	14.27%	11.23%	14.36%	23.13%	18.28%	18.45%	19.64%	22.77%	16.64%	9.41%
Net Working Capital to Revenue	16.34%	14.27%	11.23%	14.36%	23.13%	18.28%	18.45%	19.64%	22.77%	16.64%	9.41%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.77	$1.54	$1.82	$2.34	$1.88	$0.00	$0.00	$0.00	$0.00	$1.47	$0.00
Adjusted Weighted Average Basic Shares Outstanding	35.24M	35.23M	35.22M	70.43M	70.40M	35.19M	32.25M	32.24M	27.06M	27.06M	27.06M
Adjusted Diluted Earnings per Share	$1.77	$1.54	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.47	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	35.24M	35.23M	35.22M	70.43M	70.40M	35.19M	32.25M	32.24M	27.06M	27.06M	27.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.47	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	35.23M	35.22M	35.22M	35.21M	35.20M	34.49M	32.24M	28.39M	27.06M	27.06M	27.06M
Normalized Net Operating Profit after Tax (NOPAT)	390	357	347	410	352	349	350	373	365	359	515
Normalized NOPAT Margin	34.30%	29.97%	21.76%	33.76%	36.46%	32.00%	32.52%	38.34%	42.80%	35.61%	29.44%
Pre Tax Income Margin	32.57%	28.17%	21.08%	33.08%	35.35%	30.56%	30.75%	36.41%	41.52%	35.20%	40.53%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	15.40	13.66	26.05	46.59	29.38	18.00	16.42	17.21	29.11	72.38	68.55
NOPAT to Interest Expense	15.16	13.47	25.85	46.52	29.27	17.80	16.31	17.06	28.98	72.21	49.06
EBIT Less CapEx to Interest Expense	13.49	11.89	22.01	37.38	26.31	15.77	14.56	14.06	5.35	25.83	49.23
NOPAT Less CapEx to Interest Expense	13.25	11.70	21.82	37.31	26.20	15.58	14.45	13.92	5.21	25.66	29.74
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	107.36%	114.22%	120.66%	85.76%	110.87%	113.44%	119.57%	109.34%	79.10%	96.63%	128.69%
Augmented Payout Ratio	107.36%	114.22%	120.66%	85.76%	110.87%	113.44%	119.57%	109.34%	79.10%	96.63%	128.69%

This table displays calculated financial ratios and metrics derived from Westlake Chemical Partners' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.53%	-2.43%	-13.89%	7.57%	-7.48%	-18.96%	-22.51%	-41.14%	-15.10%	0.00%	0.00%
EBITDA Growth	-39.71%	-1.11%	20.21%	13.45%	-0.94%	-2.67%	3.50%	-8.35%	9.74%	0.00%	18.03%
EBIT Growth	-50.28%	-0.57%	26.86%	16.35%	-2.57%	-2.35%	6.16%	-6.77%	18.98%	0.00%	20.94%
NOPAT Growth	-51.00%	-0.85%	27.28%	16.31%	-3.12%	-2.60%	5.77%	-7.91%	17.93%	0.00%	19.15%
Net Income Growth	-52.80%	0.38%	28.75%	16.96%	-1.97%	-4.61%	3.25%	-10.87%	13.15%	0.00%	0.00%
EPS Growth	-66.67%	4.88%	37.84%	20.59%	0.00%	-12.77%	-11.90%	-27.66%	-8.70%	0.00%	0.00%
Operating Cash Flow Growth	-56.22%	23.03%	24.92%	23.70%	-27.82%	-12.16%	-12.62%	-18.46%	38.21%	0.00%	16.12%
Free Cash Flow Firm Growth	433.67%	-30.56%	121.35%	-79.25%	-83.08%	7.81%	-181.12%	-6.43%	58.16%	217.08%	1,301.16%
Invested Capital Growth	-12.04%	-6.05%	-10.66%	4.90%	5.23%	-10.96%	0.00%	-8.76%	-9.04%	-8.61%	-100.00%
Revenue Q/Q Growth	-18.08%	4.72%	-2.52%	-0.18%	-4.24%	-7.58%	21.76%	-14.14%	-16.13%	-11.63%	-7.50%
EBITDA Q/Q Growth	-37.92%	-13.14%	12.93%	-0.99%	1.83%	5.58%	6.58%	-13.55%	0.05%	12.27%	-5.62%
EBIT Q/Q Growth	-48.64%	-15.90%	17.00%	-1.61%	2.71%	7.29%	7.31%	-17.60%	2.93%	16.65%	-5.76%
NOPAT Q/Q Growth	-49.37%	-16.12%	17.19%	-1.55%	2.47%	7.67%	7.09%	-18.00%	3.01%	16.92%	-6.75%
Net Income Q/Q Growth	-51.58%	-16.05%	18.26%	-1.81%	2.97%	7.67%	7.43%	-17.70%	0.21%	16.54%	-7.26%
EPS Q/Q Growth	-67.44%	-15.69%	24.39%	-2.38%	2.44%	10.81%	8.82%	-19.05%	-10.64%	11.90%	-10.64%
Operating Cash Flow Q/Q Growth	-65.44%	5.07%	3.43%	16.57%	-2.88%	6.68%	2.42%	-31.97%	18.18%	6.13%	-4.44%
Free Cash Flow Firm Q/Q Growth	19.84%	-33.04%	509.47%	9.12%	-73.41%	120.59%	-692.38%	-11.06%	-0.61%	-84.51%	583.29%
Invested Capital Q/Q Growth	1.21%	-2.96%	-8.62%	-1.98%	-0.43%	-7.72%	7.28%	-1.67%	-8.54%	0.00%	-100.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.76%	33.99%	42.22%	35.62%	35.89%	33.87%	28.91%	33.21%	34.48%	26.75%	21.80%
EBITDA Margin	31.57%	41.66%	50.23%	43.35%	43.71%	41.11%	35.98%	41.11%	40.83%	34.23%	26.94%
Operating Margin	19.61%	31.73%	39.60%	32.95%	33.41%	31.22%	26.81%	30.47%	31.90%	25.97%	19.71%
EBIT Margin	20.18%	32.19%	40.08%	33.39%	33.88%	31.59%	27.21%	30.87%	32.17%	26.21%	19.86%
Profit (Net Income) Margin	17.80%	30.13%	37.58%	30.98%	31.49%	29.29%	25.14%	28.49%	29.72%	24.88%	18.86%
Tax Burden Percent	99.75%	99.77%	99.79%	99.77%	99.77%	99.76%	99.73%	99.77%	99.77%	99.79%	99.39%
Interest Burden Percent	88.45%	93.82%	93.97%	92.99%	93.18%	92.94%	92.64%	92.50%	92.61%	95.11%	95.58%
Effective Tax Rate	0.25%	0.23%	0.21%	0.23%	0.23%	0.24%	0.27%	0.23%	0.23%	0.21%	0.61%
Return on Invested Capital (ROIC)	19.01%	33.62%	39.93%	34.21%	33.48%	31.68%	56.40%	35.25%	41.18%	31.84%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	17.59%	31.67%	38.02%	32.35%	31.70%	29.78%	53.31%	33.23%	38.65%	30.77%	0.00%
Return on Net Nonoperating Assets (RNNOA)	6.28%	8.52%	12.62%	11.01%	10.70%	9.84%	20.66%	9.01%	10.61%	11.77%	0.00%
Return on Equity (ROE)	25.29%	42.14%	52.54%	45.23%	44.18%	41.52%	77.06%	44.26%	51.79%	43.60%	0.00%
Cash Return on Invested Capital (CROIC)	43.26%	42.67%	45.76%	27.37%	25.33%	42.07%	-139.87%	39.53%	39.87%	35.73%	200.00%
Operating Return on Assets (OROA)	16.48%	28.07%	34.76%	30.23%	30.00%	27.98%	51.12%	29.88%	35.39%	29.28%	0.00%
Return on Assets (ROA)	14.54%	26.28%	32.59%	28.04%	27.88%	25.94%	47.23%	27.57%	32.70%	27.79%	0.00%
Return on Common Equity (ROCE)	8.31%	13.90%	17.32%	14.91%	14.45%	13.49%	25.25%	13.95%	16.20%	13.61%	0.00%
Return on Equity Simple (ROE_SIMPLE)	121.69%	0.00%	132.79%	125.20%	119.65%	0.00%	120.05%	117.79%	119.03%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	46	92	109	93	95	93	86	80	98	95	81
NOPAT Margin	19.56%	31.65%	39.52%	32.87%	33.33%	31.15%	26.74%	30.40%	31.83%	25.92%	19.59%
Net Nonoperating Expense Percent (NNEP)	1.42%	1.95%	1.90%	1.86%	1.78%	1.91%	3.09%	2.03%	2.53%	1.06%	1.58%
Return On Investment Capital (ROIC_SIMPLE)	3.87%	7.47%	-	-	-	7.37%	-	-	-	7.29%	-
Cost of Revenue to Revenue	77.24%	66.01%	57.78%	64.38%	64.11%	66.13%	71.09%	66.79%	65.52%	73.25%	78.20%
SG&A Expenses to Revenue	3.15%	2.26%	2.62%	2.68%	2.49%	2.65%	2.10%	2.74%	2.57%	0.78%	2.09%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	3.15%	2.26%	2.62%	2.68%	2.49%	2.65%	2.10%	2.74%	2.57%	0.78%	2.09%
Earnings before Interest and Taxes (EBIT)	48	93	111	95	96	94	88	82	99	96	82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	75	121	139	123	124	122	116	109	126	126	112
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.08	2.90	2.84	2.88	2.81	2.46	2.49	2.46	2.45	2.35	0.00
Price to Tangible Book Value (P/TBV)	3.15	2.96	2.90	2.94	2.87	2.51	2.55	2.51	2.50	2.40	0.00
Price to Revenue (P/Rev)	0.75	0.70	0.69	0.67	0.67	0.58	0.56	0.52	0.46	0.43	0.00
Price to Earnings (P/E)	15.50	12.82	12.80	14.01	14.42	12.68	12.40	12.04	11.33	10.71	0.00
Dividend Yield	8.17%	8.31%	8.41%	8.35%	8.49%	9.65%	9.43%	9.46%	9.33%	9.66%	9.93%
Earnings Yield	6.45%	7.80%	7.81%	7.14%	6.93%	7.89%	8.06%	8.31%	8.83%	9.34%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.52	1.51	1.48	1.44	1.42	1.37	1.35	1.37	1.02	1.32	0.00
Enterprise Value to Revenue (EV/Rev)	1.47	1.37	1.38	1.42	1.45	1.27	1.28	1.13	0.75	1.03	0.00
Enterprise Value to EBITDA (EV/EBITDA)	3.49	3.07	3.10	3.48	3.60	3.20	3.40	3.25	2.40	3.47	0.00
Enterprise Value to EBIT (EV/EBIT)	4.60	3.94	3.99	4.53	4.72	4.18	4.44	4.26	3.16	4.68	0.00
Enterprise Value to NOPAT (EV/NOPAT)	4.68	4.00	4.05	4.60	4.79	4.24	4.50	4.32	3.20	4.71	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.75	3.22	3.43	3.88	4.12	3.34	3.46	3.18	2.29	3.52	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	3.30	3.42	3.05	5.40	5.76	3.07	0.00	3.32	2.44	3.53	0.52
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.50	0.48	0.48	0.48	0.47	0.47	0.46	0.46	0.00	0.44	0.00
Long-Term Debt to Equity	0.50	0.48	0.48	0.48	0.47	0.47	0.46	0.46	0.00	0.44	0.00
Financial Leverage	0.36	0.27	0.33	0.34	0.34	0.33	0.39	0.27	0.27	0.38	0.42
Leverage Ratio	1.61	1.55	1.55	1.54	1.52	1.53	1.56	1.52	1.50	1.52	1.50
Compound Leverage Factor	1.43	1.45	1.46	1.43	1.41	1.42	1.44	1.41	1.39	1.45	1.44
Debt to Total Capital	33.23%	32.52%	32.30%	32.37%	32.03%	31.82%	31.70%	31.53%	0.00%	30.66%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	33.23%	32.52%	32.30%	32.37%	32.03%	31.82%	31.70%	31.53%	0.00%	30.66%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	44.78%	45.01%	45.26%	45.27%	45.68%	45.89%	45.92%	45.95%	67.39%	46.94%	0.00%
Common Equity to Total Capital	21.99%	22.47%	22.44%	22.36%	22.29%	22.29%	22.38%	22.52%	32.61%	22.40%	0.00%
Debt to EBITDA	0.87	0.79	0.79	0.82	0.85	0.85	0.84	0.85	0.00	0.85	0.00
Net Debt to EBITDA	0.54	0.41	0.45	0.69	0.73	0.52	0.70	0.52	0.00	0.71	0.00
Long-Term Debt to EBITDA	0.87	0.79	0.79	0.82	0.85	0.85	0.84	0.85	0.00	0.85	0.00
Debt to NOPAT	1.17	1.03	1.02	1.09	1.13	1.12	1.11	1.13	0.00	1.15	0.00
Net Debt to NOPAT	0.72	0.53	0.59	0.91	0.97	0.69	0.93	0.69	0.00	0.97	0.00
Long-Term Debt to NOPAT	1.17	1.03	1.02	1.09	1.13	1.12	1.11	1.13	0.00	1.15	0.00
Altman Z-Score	1.82	2.34	2.38	2.39	2.37	2.19	2.17	2.25	2.49	2.43	0.00
Noncontrolling Interest Sharing Ratio	67.14%	67.01%	67.04%	67.02%	67.30%	67.51%	67.23%	68.48%	68.72%	68.78%	68.94%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.37	4.35	4.53	4.68	5.21	4.02	3.06	3.33	4.51	3.67	0.00
Quick Ratio	1.35	4.27	4.45	2.67	2.90	3.93	1.88	3.27	4.41	2.63	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	190	159	237	39	36	228	-1,109	187	210	212	1,367
Operating Cash Flow to CapEx	286.92%	983.15%	810.95%	1,197.64%	1,069.94%	838.43%	600.39%	2,183.54%	1,144.60%	1,415.40%	880.03%
Free Cash Flow to Firm to Interest Expense	34.32	27.48	35.35	5.84	5.41	34.43	-172.30	30.61	28.78	45.02	375.08
Operating Cash Flow to Interest Expense	8.27	22.95	18.82	18.33	15.89	16.24	15.68	16.11	19.80	26.06	31.69
Operating Cash Flow Less CapEx to Interest Expense	5.39	20.62	16.50	16.80	14.40	14.30	13.07	15.37	18.07	24.22	28.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.87	0.87	0.91	0.89	0.89	1.88	0.97	1.10	1.12	0.00
Accounts Receivable Turnover	15.89	20.32	15.92	18.40	16.79	13.29	0.00	12.94	14.92	12.27	0.00
Inventory Turnover	189.12	168.89	177.30	204.13	151.89	175.65	0.00	181.43	171.71	178.62	0.00
Fixed Asset Turnover	1.19	1.23	1.22	1.27	1.23	1.23	0.00	1.37	1.53	1.57	0.00
Accounts Payable Turnover	11.51	20.54	18.96	23.56	29.21	19.89	0.00	16.80	26.67	25.51	0.00
Days Sales Outstanding (DSO)	22.97	17.97	22.93	19.84	21.74	27.47	0.00	28.21	24.47	29.74	0.00
Days Inventory Outstanding (DIO)	1.93	2.16	2.06	1.79	2.40	2.08	0.00	2.01	2.13	2.04	0.00
Days Payable Outstanding (DPO)	31.71	17.77	19.25	15.49	12.50	18.35	0.00	21.72	13.69	14.31	0.00
Cash Conversion Cycle (CCC)	-6.81	2.36	5.74	6.13	11.65	11.20	0.00	8.50	12.91	17.48	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,049	1,036	1,068	1,169	1,192	1,103	1,195	1,114	1,133	1,239	0.00
Invested Capital Turnover	0.97	1.06	1.01	1.04	1.00	1.02	2.11	1.16	1.29	1.23	0.00
Increase / (Decrease) in Invested Capital	-144	-67	-127	55	59	-136	1,195	-107	-113	-117	-1,286
Enterprise Value (EV)	1,598	1,560	1,580	1,688	1,696	1,511	1,617	1,531	1,155	1,634	669
Market Capitalization	814	800	790	796	782	688	704	702	712	687	669
Book Value per Share	$7.51	$7.84	$7.88	$7.84	$7.90	$7.95	$8.01	$8.11	$8.24	$8.29	$0.00
Tangible Book Value per Share	$7.34	$7.67	$7.72	$7.67	$7.73	$7.78	$7.85	$7.94	$8.07	$8.12	$0.00
Total Capital	1,203	1,229	1,237	1,235	1,248	1,256	1,261	1,268	890	1,303	0.00
Total Debt	400	400	400	400	400	400	400	400	0.00	400	0.00
Total Long-Term Debt	400	400	400	400	400	400	400	400	0.00	400	0.00
Net Debt	246	207	230	334	344	247	334	246	-157	335	0.00
Capital Expenditures (CapEx)	16	13	16	10	9.77	13	17	4.51	13	8.66	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-94	-7.32	19	117	126	17	90	0.57	24	114	0.00
Debt-free Net Working Capital (DFNWC)	60	186	188	183	181	170	156	154	181	179	0.00
Net Working Capital (NWC)	60	186	188	183	181	170	156	154	181	179	0.00
Net Nonoperating Expense (NNE)	4.18	4.43	5.36	5.38	5.23	5.54	5.15	5.04	6.48	3.81	3.01
Net Nonoperating Obligations (NNO)	246	207	230	334	344	247	334	246	243	335	0.00
Total Depreciation and Amortization (D&A)	27	27	28	28	28	28	28	27	27	29	29
Debt-free, Cash-free Net Working Capital to Revenue	-8.62%	-0.64%	1.62%	9.81%	10.75%	1.41%	7.14%	0.04%	1.58%	7.16%	0.00%
Debt-free Net Working Capital to Revenue	5.54%	16.34%	16.47%	15.37%	15.52%	14.27%	12.37%	11.39%	11.76%	11.23%	0.00%
Net Working Capital to Revenue	5.54%	16.34%	16.47%	15.37%	15.52%	14.27%	12.37%	11.39%	11.76%	11.23%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	$0.43	$0.51	$0.41	$0.42	$0.41	$0.37	$0.34	$0.42	$0.47	$0.00
Adjusted Weighted Average Basic Shares Outstanding	35.24M	35.24M	35.24M	35.23M	35.23M	35.22M	35.23M	35.22M	35.22M	35.22M	0.00
Adjusted Diluted Earnings per Share	$0.14	$0.43	$0.51	$0.41	$0.42	$0.41	$0.37	$0.34	$0.42	$0.47	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	35.24M	35.24M	35.24M	35.23M	35.23M	35.22M	35.23M	35.22M	35.22M	35.22M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	35.24M	35.23M	35.24M	35.23M	35.23M	35.22M	35.23M	35.22M	35.22M	35.22M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	46	92	109	93	95	93	86	80	98	95	81
Normalized NOPAT Margin	19.56%	31.65%	39.52%	32.87%	33.33%	31.15%	26.74%	30.40%	31.83%	25.92%	19.59%
Pre Tax Income Margin	17.85%	30.20%	37.66%	31.05%	31.56%	29.35%	25.20%	28.56%	29.79%	24.93%	18.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.66	16.18	16.57	14.27	14.65	14.16	13.60	13.33	13.53	20.44	22.62
NOPAT to Interest Expense	8.40	15.91	16.34	14.04	14.42	13.96	13.36	13.13	13.39	20.21	22.31
EBIT Less CapEx to Interest Expense	5.78	13.84	14.25	12.74	13.17	12.22	10.98	12.59	11.80	18.60	19.02
NOPAT Less CapEx to Interest Expense	5.51	13.57	14.02	12.51	12.93	12.03	10.75	12.39	11.66	18.37	18.71
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	114.10%	107.36%	106.42%	109.64%	112.55%	114.22%	126.87%	130.09%	125.05%	120.66%	0.00%
Augmented Payout Ratio	114.10%	107.36%	106.42%	109.64%	112.55%	114.22%	126.87%	130.09%	125.05%	120.66%	0.00%

Frequently Asked Questions About Westlake Chemical Partners' Financials

When does Westlake Chemical Partners's fiscal year end?

According to the most recent income statement we have on file, Westlake Chemical Partners' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Westlake Chemical Partners' net income changed over the last 10 years?

Westlake Chemical Partners' net income were at $369.16 million at the end of 2024, a 10.3% increase from 2023, and a 27.6% decrease since 2014. See Westlake Chemical Partners' forecast for analyst expectations on what’s next for the company.

What is Westlake Chemical Partners's operating income?

Westlake Chemical Partners's total operating income in 2024 was $390.44 million, based on the following breakdown:

Total Gross Profit: $418.94 million
Total Operating Expenses: $28.50 million

How has Westlake Chemical Partners revenue changed over the last 10 years?

Over the last 10 years, Westlake Chemical Partners' total revenue changed from $1.75 billion in 2014 to $1.14 billion in 2024, a change of -35.1%.

How much debt does Westlake Chemical Partners have?

Westlake Chemical Partners' total liabilities were at $458.64 million at the end of 2024, a 0.4% decrease from 2023, and a 75.4% increase since 2014.

How much cash does Westlake Chemical Partners have?

In the past 10 years, Westlake Chemical Partners' cash and equivalents has ranged from $17.06 million in 2021 to $169.56 million in 2015, and is currently $58.32 million as of their latest financial filing in 2024.

How has Westlake Chemical Partners' book value per share changed over the last 10 years?

Over the last 10 years, Westlake Chemical Partners' book value per share changed from 3.23 in 2014 to 7.84 in 2024, a change of 142.3%.

Related Companies

This page (NYSE:WLKP) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Westlake Chemical Partners (WLKP) Financials

Frequently Asked Questions About Westlake Chemical Partners' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Westlake Chemical Partners (WLKP) Financials

Annual Income Statements for Westlake Chemical Partners

Quarterly Income Statements for Westlake Chemical Partners

Annual Cash Flow Statements for Westlake Chemical Partners

Quarterly Cash Flow Statements for Westlake Chemical Partners

Annual Balance Sheets for Westlake Chemical Partners

Quarterly Balance Sheets for Westlake Chemical Partners

Annual Metrics And Ratios for Westlake Chemical Partners

Quarterly Metrics And Ratios for Westlake Chemical Partners

Frequently Asked Questions About Westlake Chemical Partners' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools